Europe and MENA Wound Care Market – By Product, By Application, By Mode of Purchase, By End Use, and Forecast, 2024 – 2032

Europe and MENA Wound Care Market Size

Europe and MENA wound care market size was valued at around USD 7.5 billion in 2023 and is estimated to grow at 6% CAGR from 2024 to 2032. Wound care refers to the medical treatment and management of wounds, which are injuries to the skin or underlying tissues caused by trauma, surgery, or chronic conditions. The primary goals of wound care are to promote healing, prevent infection, and minimize scarring.
 

The rising incidence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is significantly increasing the demand for advanced wound care products across Europe and the Middle East. In Europe, the European Wound Management Association (EWMA) estimates that approximately four million people are affected by chronic wounds annually, highlighting the critical need for effective wound care solutions.
 

Furthermore, technological advancements, such as bioactive dressings and negative pressure wound therapy, are boosting demand by improving treatment outcomes and enhancing patient comfort. Similarly, in the Middle East, the growing prevalence of chronic conditions and increasing healthcare infrastructure investments are contributing to a rising need for advanced wound care products.
 

Europe and MENA Wound Care Market Trends

• The prevalence of chronic diseases such as diabetes, obesity, and vascular disorders across Europe is leading to an increase in chronic wounds, including diabetic foot ulcers and pressure ulcers. This trend is driving up the demand for advanced wound care solutions, encompassing dressings, negative pressure wound therapy (NPWT), and skin substitutes.
   
• Advancements in wound care products are broadening treatment possibilities. These innovations include bioactive dressings, antimicrobial dressings, and progression factor-infused therapies. Additionally, the adoption of artificial intelligence (AI) and digital wound management tools for monitoring healing progress is gaining traction in Europe.
   
• Governments in the Middle East and North Africa (MENA) region are investing in healthcare infrastructure improvements, with an emphasis on enhancing access to advanced treatments for chronic conditions. This investment has resulted in increased availability and utilization of advanced wound care products in hospitals and clinics throughout the region.
   

Europe and MENA Wound Care Market Analysis

Based on product, the market is segmented into advanced wound dressings, surgical wound care, traditional wound care, wound therapy devices, and wound care biologics. The advanced wound dressings segment dominated the market with the largest revenue of USD 2.4 billion in 2023.
 

• Advanced wound dressings, such as those with bioactive materials or negative pressure systems, significantly accelerate the healing process by creating optimal environments for wound repair. They often promote faster epithelialization and collagen formation compared to traditional dressings.
   
• For example, data from the National Institutes of Health (NIH) highlights that Negative Pressure Wound Therapy (NPWT) is essential in advanced wound care, demonstrating excellent effectiveness in accelerating healing for complex acute and chronic wounds by promoting tissue granulation and reducing infection risks.
   
• Many advanced dressings also incorporate antimicrobial agents or silver nanoparticles to further reduce the risk of infection, which is especially beneficial for chronic or high-risk wounds.
   

Based on application, the Europe and MENA wound care market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment is further sub-segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. Whereas the acute wounds segment is further bifurcated into surgical wounds, traumatic wounds, and burns. The acute wounds segment dominated the market and was valued at USD 4.2 billion in 2023.
 

• Acute wounds are injuries that typically result from trauma or surgery and follow a predictable healing process. These wounds, such as surgical incisions, lacerations, and abrasions, generally heal within a few weeks if managed properly.
   
• Effective care for acute wounds involves cleaning the wound, applying appropriate dressings to protect the area, and monitoring for signs of infection.
   
• A significant increase in healthcare spending and greater awareness of the importance of wound care have led governments and healthcare organizations to actively promote advanced wound care solutions to improve patient outcomes. This supportive environment, along with a growing trend toward outpatient care and shorter hospital stays, has fueled the demand for wound care products that facilitate quicker recovery at home.
   

Based on mode of purchase, the Europe and MENA wound care market is bifurcated into prescribed and non-prescribed. The prescribed segment held the largest revenue of USD 5.4 billion in 2023.
 

• The growing prevalence of chronic wounds, driven by factors such as an aging population and rising rates of diabetes and obesity, has significantly increased the need for prescribed advanced wound care solutions. These solutions include physician-recommended treatments such as advanced dressings, antimicrobial agents, and innovative technologies like Negative Pressure Wound Therapy (NPWT).
   
• These prescribed approaches are crucial for managing chronic wounds, including diabetic ulcers, pressure sores, and venous leg ulcers, which affect millions of individuals globally.
   
• Physicians often prescribe advanced dressings, ointments, and therapies aimed at promoting faster tissue regeneration. These treatments are specially designed to maintain a moist healing environment, prevent infections, and stimulate cell growth, ultimately reducing the risk of complications such as infections and persistent chronic wounds.
   

Based on end use, the Europe and MENA wound care market is segmented into hospitals, specialty clinics, home care settings, and other end users. The hospitals segment held the largest revenue of USD 3 billion in 2023.
 

• The increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, among the aging population significantly boosts the demand for advanced wound care solutions within hospital settings.
   
• Additionally, hospitals are increasingly adopting cutting-edge technologies and innovative products to improve patient outcomes and reduce wound-related complications.
   
• Moreover, the expansion of healthcare infrastructure and investments in hospital-based wound care services across the EMENA region contribute to robust market expansion.
   

The Europe and MENA wound care market is forecasted to reach USD 12.7 billion by 2032. Europe dominated the market with the largest revenue of USD 6.9 billion in 2023.
 

• The high prevalence of chronic diseases, such as diabetes and cardiovascular conditions, in Europe is significantly stimulating the demand for wound care products. According to the European Society of Cardiology, cardiovascular disease (CVD) is a major health issue in the region, causing 3.9 million deaths annually across Europe and over 1.8 million within the European Union.
   
• CVD accounts for 45% of all deaths in Europe and 37% in the EU, remaining the leading cause of death for men in all but 12 European countries, and the primary cause of mortality for those under 65 years of age.
   
• Consequently, these chronic conditions frequently lead to complex wounds, such as diabetic foot ulcers and surgical wounds, which require specialized care.
   

The market in UK is expected to experience significant and promising development from 2024 to 2032.
 

• The UK’s aging population is a significant driver of the wound care market. Older adults are more prone to chronic wounds, such as pressure ulcers, venous leg ulcers, and diabetic foot ulcers, due to age-related health conditions like reduced mobility, diabetes, and poor circulation. As the number of elderly individuals continues to grow, the demand for advanced wound care solutions is expected to rise.
   
• Furthermore, the NHS, the largest healthcare provider in the UK, is focusing on reducing healthcare costs while ensuring high-quality patient care. There is a growing emphasis on outpatient and community-based wound care to alleviate pressure on hospitals. This shift has led to increased adoption of home-based wound care therapies and dressings that promote faster healing and minimize hospital admissions.
   

The Europe and MENA wound care market in Saudi Arabia is expected to experience significant and promising expansion from 2024 to 2032.
 

• Saudi Arabia has one of the highest diabetes prevalence rates globally, contributing to a large number of patients suffering from diabetic foot ulcers.
   
• According to the International Diabetes Federation, approximately 17.7% of the adult population in Saudi Arabia was living with diabetes in 2021.
   
• Additionally, rising rates of obesity and related cardiovascular diseases in Saudi Arabia have led to an increase in chronic wounds, such as venous leg ulcers and pressure ulcers.
   

Europe and MENA Wound Care Market Share

The market is a fragmented, dynamic, and rapidly evolving market, characterized by significant technological advancements and competitive activities among leading players. Key market participants, including Convatec Group PLC, Essity AB, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and 3M Company, are driving innovation through advanced wound care, expanded product offerings, and strategic collaborations.
 

The market is influenced by trends such as the development of advanced wound dressings, the expansion into emerging markets, and efforts to navigate complex regulatory environments. While challenges such as high development costs and regulatory hurdles persist, there are substantial opportunities for expansion in personalized medicine, advanced tissue engineering, and scalable bioprinting solutions.
 

Europe and MENA Wound Care Market Companies

Some of the eminent market participants operating in the Europe and MENA wound care industry include:

• Advancis Medical
• B. Braun Melsungen
• Baxter International
• Coloplast
• Convatec Group
• Essity
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Medline Industries
• Medtronic
• Mölnlycke Health Care
• Smith & Nephew
• URGO Medical
• 3M Company
   

Europe and MENA Wound Care Industry News:

• In July 2024, Mölnlycke Health Care AB, a leading global MedTech company specializing in solutions for wound care and surgical procedures, announced an investment of USD 15 million in MediWound Ltd., through a definitive share purchase agreement as part of a private investment in public equity (PIPE). This investment in MediWound, Ltd. enhanced Mölnlycke Health Care AB's portfolio of innovative wound care solutions.
   
• In January 2022, Convatec Group PLC, announced the acquisition of Triad Life Sciences Inc., a US-based medical device company that developed biologically derived innovative products aimed at addressing unmet clinical needs in surgical wounds, chronic wounds, and burns. This acquisition enhanced Convatec’s product portfolio and strengthen its position in the EMENA wound care market.
   

The Europe and MENA wound care market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Advanced wound dressings
  • Foam dressings
  • Hydrocolloid dressings
  • Film dressings
  • Alginate dressings
  • Hydrogel dressings
  • Collagen dressings
  • Other advanced dressings
• Surgical wound care
  • Sutures & staplers
  • Tissue adhesives and sealants
  • Anti-infective dressings
• Traditional wound care
  • Medical tapes
  • Cotton
  • Bandages
  • Gauzes
  • Sponges
  • Cleansing agents
• Wound therapy devices
  • Negative pressure wound therapy
  • Oxygen and hyperbaric oxygen equipment
  • Electric stimulation devices
  • Pressure relief devices
  • Other wound therapy devices
• Wound care biologics
  • Skin substitutes
    • Biological
      • Allograft
      • Xenograft
      • Other biologicals
    • Synthetic
  • Topical agents

Market, By Application

• Chronic wounds
  • Diabetic foot ulcers
  • Pressure ulcers
  • Venous leg ulcers
  • Other chronic wounds
• Acute wounds
  • Surgical wounds
  • Traumatic wounds
  • Burns

Market, By Mode of Purchase

• Prescribed
• Non-prescribed

Market, By End Use

• Hospitals
• Specialty clinics
• Home care settings
• Other end users

The above information is provided for the following regions and countries:

• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Ukraine
  • Romania
  • Netherlands
  • Belgium
  • Sweden
  • Czech Republic
  • Greece
  • Portugal
  • Hungary
  • Austria
  • Switzerland
  • Serbia
  • Bulgaria
  • Denmark
  • Slovakia
  • Finland
  • Norway
  • Ireland
  • Croatia
  • Slovenia
  • Malta 
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • Algeria
  • Iran
  • Turkey